◆ TICKERBASEOpen interactive view →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › S › SSII

SS Innovations International Inc. Common Stock (SSII) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · MEDICAL DEVICES · DATA UPDATED 2026-09-24

SS Innovations International Inc. Common Stock (SSII) operates in the MEDICAL DEVICES industry and is headquartered in Gurugram, India with about 483 employees. Its market capitalization is roughly $467 million. In the fiscal year ended 2025-12-31, SSII reported $42M in revenue and ($12M) in net income.

SS Innovations International, Inc., together with its subsidiaries, operates as a commercial-stage surgical robotics company in India, Philippines, Indonesia, South America, Iraq, Cyprus, Oman, United Arab Emirates (UAE), Nepal, and internationally.

Interactive charts & full statements → Open the SSII valuation workbench →

SSII Revenue & Earnings History — Annual Income Statement

Income statementTTM → 2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
Total Revenue$52M$42M$21M$6M$1M$0M$0M$0M————
Gross Profit$25M$20M$8M$1M$0M$0M$0M$0M$0M$0M——
Gross Margin %47.0%46.0%40.9%12.1%33.6%———————
Operating Income (EBIT)($8M)($8M)($19M)($21M)($6M)($3M)($1M)($3M)($1M)($1M)$0M$0M
Operating Margin %-16.2%-19.3%-91.9%-351.5%-389.4%———————
Net Income($12M)($12M)($19M)($21M)($6M)($3M)($1M)($3M)($1M)($1M)$0M$0M
Net Margin %-23.7%-28.5%-92.7%-356.2%-384.1%———————
EBITDA($6M)($6M)($18M)($20M)($5M)($3M)($1M)($3M)($1M)($1M)$0M$0M
Earnings Per Share (EPS)$-0.06$-0.06$-0.11$-0.16$-1.41$-1.57$-0.48$-1.57$-0.46$-0.53$-0.25$-0.00
Shares Outstanding (M)209M199M182M128M4M2M2M2M2M2M2M2M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SSII Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Total Revenue$14M$11M$15M$13M$10M$5M$6M$4M
Gross Profit$7M$5M$6M$6M$6M$1M$3M$2M
Gross Margin %50.9%45.0%43.9%48.0%59.2%21.2%53.9%52.8%
Operating Income (EBIT)($2M)($4M)($1M)($2M)$0M($6M)($8M)($3M)
Operating Margin %-16.3%-33.0%-5.1%-14.3%1.0%-115.7%-135.7%-73.1%
Net Income($3M)($4M)($2M)($4M)$0M($6M)($7M)($3M)
Net Margin %-19.1%-32.3%-17.0%-29.0%-2.6%-110.9%-132.5%-74.0%
EBITDA($2M)($3M)$0M($1M)$1M($5M)($7M)($3M)
Earnings Per Share (EPS)$-0.01$-0.02$-0.01$-0.02$-0.00$-0.03$-0.04$-0.02
Shares Outstanding (M)209M205M199M203M203M189M182M182M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SSII Free Cash Flow History

Cash flowTTM → 2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Cash from Operations (CFO)($16M)($19M)($10M)($15M)($6M)$0M$0M$0M$0M$0M$0M
Capital Expenditures (CapEx)$3M$4M$1M$0M$5M$0M$0M$0M$0M$0M$0M
Free Cash Flow (FCF)($18M)($22M)($10M)($16M)($11M)$0M$0M$0M$0M$0M$0M
FCF Margin %-34.8%-52.3%-49.2%-269.0%-723.7%——————

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SSII Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Cash from Operations (CFO)($4M)($2M)($2M)($7M)($3M)($6M)($3M)($3M)
Capital Expenditures (CapEx)$0M$0M$2M$1M$0M$1M$0M$2M
Free Cash Flow (FCF)($4M)($2M)($3M)($8M)($4M)($7M)($3M)($4M)
FCF Margin %-31.5%-21.3%-22.2%-64.1%-37.7%-136.2%-60.2%-96.9%

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SSII Balance Sheet History

Balance sheet2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Total Assets$97M$74M$42M$25M$7M$0M$0M$0M$0M$1M$0M
Cash & Cash Equivalents$14M$3M$0M$7M$0M$0M$0M$0M$0M$0M$0M
Total Liabilities$44M$36M$29M$11M$10M$1M$1M$1M$0M$0M$1M
Total Debt (Short + Long-Term)$1M$12M$16M$6M$7M$0M$0M$0M$0M$0M$0M
Total Shareholders' Equity$53M$38M$13M$14M($3M)($1M)($1M)($1M)$0M$0M$0M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive SSII viewer.

Other Companies in MEDICAL DEVICES

← SSHYAll “S” companiesSSIT →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.